Retrospective Study to Evaluate the Effectiveness of the Approach to Enuresis in Our Center
1 other identifier
observational
200
1 country
1
Brief Summary
Retrospective study to evaluate the effectiveness of the approach to enuresis at IRCCS Azienda Ospedaliero-Universitaria of Bologna Policlinico di Sant'Orsola, Italy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2022
CompletedFirst Submitted
Initial submission to the registry
January 2, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 8, 2025
December 1, 2024
3.9 years
January 2, 2025
January 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Daily urinary frequency
increase (≥8 micturitions/day) or decrease (≤3 micturitions/day)
at baseline
Maximum Voided Volume (MVV)
volume of urine emitted in 24 hours, excluding first morning urine
at baseline
Bladder capacity
reduction (\<35% of expected bladder capacity) or increase (\> 150% of expected bladder capacity)
at baseline
Eligibility Criteria
Since this is a descriptive study, a formal calculation of sample size is not expected. However, about 150-200 subjects are expected to be enrolled.
You may qualify if:
- Patients of either sex under the age of 18 years at the time of the first outpatient visit;
- Patients clinically evaluated in the outpatient clinic during the period 01/05/2019- 31/05/2021 with a diagnosis of enuresis;
- Patients presenting at least two outpatient follow-ups;
- Informed consent signed by parent or legal guardian.
You may not qualify if:
- Patients older than 18 years of age;
- Patients who lack completed night and daily diaries;
- Patients with continuous incontinence;
- Patients with neurological disorders and/or signs of spinal occult dysraphism;
- Patients with a severe cognitive disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, 40138, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Pasini, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2025
First Posted
January 8, 2025
Study Start
February 10, 2022
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
January 8, 2025
Record last verified: 2024-12